Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ipsen Pharmaceuticals
Biotech
Ipsen joins ADC race via $900M biobuck deal with Sutro
Ipsen is the newest entrant in the antibody-drug conjugate race, handing over around $90 million in near-term payments to Sutro Biopharma
James Waldron
Apr 2, 2024 7:26am
Cell death biotech folds in 'challenging funding environment'
Jul 11, 2023 4:00am
BMS CEO set to leave after 8-year run—Chutes & Ladders
Apr 28, 2023 9:30am
FDA agrees to give Ipsen's rare disease drug another look
Mar 17, 2023 7:12am
Irlab's Ipsen-partnered Parkinson's drug flunks phase 2 trial
Jan 18, 2023 10:08am
BioCryst leaves ultra-rare disease efforts in hands of peers
Nov 1, 2022 10:00am